Eris Lifesciences Shareholding Pattern
- Market cap
- ₹15,937 crore
- P/E
- 24.8
- P/B
- 4.08
- ROE
- 18.3%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 54.14% of Eris Lifesciences (+0.22 pp from 31-MAR-2026), foreign institutional investors 5.75%, domestic institutions 20.72% and the public 19.40%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Eris Lifesciences shareholding pattern — frequently asked questions
What is the promoter holding in Eris Lifesciences?
Promoters held 54.14% of Eris Lifesciences as of 30-JUN-2026, up 0.22 pp from 53.92% in 31-MAR-2026.
How much do FIIs hold in Eris Lifesciences?
Foreign institutional investors held 5.75% of Eris Lifesciences as of 30-JUN-2026, a change of -0.64 pp from the previous quarter.
How much do domestic institutions hold in Eris Lifesciences?
Domestic institutional investors, including mutual funds and insurers, held 20.72% of Eris Lifesciences as of 30-JUN-2026 (+0.37 pp from the previous quarter).
Who owns Eris Lifesciences?
As of 30-JUN-2026, Eris Lifesciences' shareholders were promoters (54.14%), foreign institutional investors 5.75%, domestic institutions 20.72% and the public 19.40%, as filed with the stock exchanges.
Same Data For Peers
Trade Eris Lifesciences With ATS
Track ERIS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.